Implantable medical devices and hardware are prolific in medicine, but hardware associated infections remain a major issue.
OBJECTIVE:
To develop and evaluate a novel, biologic antimicrobial coating for medical implants.
METHODS:
Electrochemically compacted collagen sheets with and without crosslinked heparin were synthesized per a protocol developed by our group. Sheets were incubated in antibiotic solution (gentamicin or moxifloxacin) overnight, and in vitro activity was assessed with five-day diffusion assays against Pseudomonas aeruginosa. Antibiotic release over time from gentamicin-infused sheets was determined using in vitro elution and high performance liquid chromatography (HPLC).
RESULTS:
Collagen-heparin-antibiotic sheets demonstrated larger growth inhibition zones against P. aeruginosa compared to collagen-antibiotic alone sheets. This activity persisted for five days and was not impacted by rinsing sheets prior to evaluation. Rinsed collagen-antibiotic sheets did not produce any inhibition zones. Elution of gentamicin from collagen-heparin-gentamicin sheets was gradual and remained above the minimal inhibitory concentration for gentamicin-sensitive organisms for 29 days. Conversely, collagen-gentamicin sheets eluted their antibiotic load within 24 hours. Overall, heparin-associated sheets demonstrated larger inhibition zones against P. aeruginosa and prolonged elution profile via HPLC.
CONCLUSION:
We developed a novel, local antibiotic delivery system that could be used to coat medical implants/hardware in the future and reduce post-operative infections.
AtreyaA.R.CookJ.R. and LindenauerP.K., Complications arising from cardiac implantable electrophysiological devices: Review of epidemiology, pathogenesis and prevention for the clinician, Postgr Med128 (2016), 223–230.
2.
VanEppsJ.S. and YoungerJ.G., Implantable device-related infection, Shock46 (2016), 597–608.
3.
VinhD.C. and EmbilJ.M., Device-related infections: A review, J Long Term Eff Med Implant15 (2005), 467–488.
4.
SchierholzJ.M. and BeuthJ., Implant infections: A haven for opportunistic bacteria, J Hosp Infect49 (2001), 87–93.
5.
ArciolaC.R.CampocciaD.SpezialeP.MontanaroL. and CostertonJ.W., Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials, Biomaterials33 (2012), 5967–5982.
6.
DibartolaA.C.SwearingenM.C.GrangerJ.F.StoodleyP. and DusaneD.H., Biofilms in orthopedic infections: A review of laboratory methods, APMIS125 (2017), 418–428.
7.
ChandraJ.KuhnD.M.MukherjeeP.K.HoyerL.L.McCormickT. and GhannoumM.A., Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance, J Bacteriol183 (2001), 5385–5394.
8.
DavidsonH.PoonM.SaundersR.ShapiroI.M.HickokN.J. and AdamsC.S., Tetracycline tethered to titanium inhibits colonization by Gram-negative bacteria, J Biomed Mater Res B Appl Biomater103(7) (2015), 1381–1389.
9.
DomingoF.DaleE.GaoC.GrovesC.StanleyD.MaxwellR.A., A single-center retrospective review of postoperative infectious complications in the surgical management of mandibular fractures: Postoperative antibiotics add no benefit, J Trauma Acute Care Surg81 (2016), 1109–1114.
10.
DurandM.L.YarlagaddaB.B.RichD.L.LinD.T.EmerickK.S.RoccoJ.W., The time course and microbiology of surgical site infections after head and neck free flap surgery, Laryngoscope125 (2015), 1084–1089.
11.
NielsenJ.C.GerdesJ.C. and VarmaN., Infected cardiac-implantable electronic devices: Prevention, diagnosis, and treatment, Eur Hear J36 (2015), 2484–2490.
12.
Hernandez RosaJ.VillanuevaN.L.Sanati-MehrizyP.FactorS.H. and TaubP.J., Review of maxillofacial hardware complications and indications for salvage, Craniomaxillofac Trauma Reconstr9 (2016), 134–140.
13.
KolekM.J.PatelN.J.ClairW.K.WhalenS.P.RottmanJ.N.KanagasundramA., Efficacy of a bio-absorbable antibacterial envelope to prevent cardiac implantable electronic device infections in high-risk subjects, J Cardiovasc Electrophysiol26 (2015), 1111–1116.
14.
StewartS.BarrS.EngilesJ.HickokN.J.ShapiroI.M.RichardsonD.W., Vancomycin-modified implant surface inhibits biofilm formation and supports bone-healing in an infected osteotomy model in sheep: A proof-of-concept study, J Bone Jt Surg Am94 (2012), 1406–1415.
15.
DarouicheR.O.MansouriM.D.ZakareviczD.AlsharifA. and LandonG.C., In vivo efficacy of antimicrobial-coated devices, J Bone Jt Surg Am89 (2007), 792–797.
16.
AltV.BitschnauA.OsterlingJ.SewingA.MeyerC.KrausR., The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model, Biomaterials27 (2006), 4627–4634.
17.
Sakiyama-ElbertS.E., Incorporation of heparin into biomaterials, Acta Biomater10(4) (2014), 1581–1587.
18.
VulicK. and ShoichetM.S., Affinity-based drug delivery systems for tissue repair and regeneration, Biomacromolecules15 (2014), 3867–3880.
19.
YounesiM.IslamA.KishoreV.PanitS. and AkkusO., Fabrication of compositionally and topographically complex robust tissue forms by 3D-electrochemical compaction of collagen, Biofabrication7 (2015), 35001.
20.
BonfieldT.L.HodgesC.A.CottonC.U. and DrummM.L., Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection, J Leukoc Biol92 (2012), 1111–1122.
21.
ErdemA.GundoganN.U.UsubutunA.KilincK.ErdemS.R.KaraA., The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats, Nephrol Dial Transpl15 (2000), 1175–1182.
22.
RyanJ.A., Colorimetric determination of gentamicin, kanamycin, tobramycin, and amikacin aminoglycosides with 2,4-dinitrofluorobenzene, J Pharm Sci73 (1984), 1301–1302.
23.
StravinskasM.HorstmannP.FergusonJ.HettwerW.NilssonM.TaraseviciusS., Pharmacokinetics of gentamicin eluted from a regenerating bone graft substitute: In vitro and clinical release studies, Bone Jt Res5(9) (2016), 427–435.
24.
HoshiR.A.Van LithR.JenM.C.AllenJ.B.LapidosK.A. and AmeerG., The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts, Biomaterials34 (2013), 30–41.
25.
LiangY. and KiickK.L., Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications, Acta Biomater10 (2014), 1588–1600.
SolbergB.GutowA. and BaumgaertnerM., Efficacy of gentamycin-impregnated resorbable hydroxyapatite cement in treating osteomyelitis in a rat model, J Orthop Trauma13(2) (1999), 102–106.
28.
ZenderC.A.MehtaV.PittmanA.L.FeustelP.J. and JaberJ.J., Etiologic causes of late osteocutaneous free flap failures in oral cavity cancer reconstruction, Laryngoscope122 (2012), 1474–1479.
29.
DayK.E.DesmondR.MagnusonJ.S.CarrollW.R. and RosenthalE.L., Hardware removal after osseous free flap reconstruction, Otolaryngol - Head Neck Surg (United States)150(1) (2014), 40–46.
30.
YarlagaddaB.B.DeschlerD.G.RichD.L.LinD.T.EmerickK.S.RoccoJ.W., Head and neck free flap surgical site infections in the era of the Surgical Care Improvement Project, Head Neck38 Suppl 1 (2016), E392–E398.
31.
LiZ.ZhouZ.LiP.ZengW.QingH. and TangW., Retrospective study on multidrug-resistant bacterium infections after rigid internal fixation of mandibular fracture, J Oral Maxillofac Surg74 (2016), 770–777.
32.
KishoreV.UquillasJ.A.DubikovskyA.AlshehabatM.A.SnyderP.W.BreurG.J., In vivo response to electrochemically aligned collagen bioscaffolds, J Biomed Mater Res B Appl Biomater100 (2012), 400–408.
33.
VargaM.SixtaB.BemR.MatiaI.JirkovskaA. and AdamecM., Application of gentamicin-collagen sponge shortened wound healing time after minor amputations in diabetic patients - A prospective, randomised trial, Arch Med Sci10 (2014), 283–287.
34.
YetimI.OzkanO.V.DervisogluA.ErzurumluK. and CanbolantE., Effect of local gentamicin application on healing and wound infection in patients with modified radical mastectomy: A prospective randomized study, J Int Med Res38 (2010), 1442–1447.
